Urinary Expression of Novel Tissue Markers of Kidney Injury Following Ureteroscopy, Shock Wave Lithotripsy and in Normal Healthy Controls
CUA Online Library. Fahmy N. 06/22/13; 31445; UP-66
Disclosure(s): Lawson Health Research Institute - Internal Research Fund
CLICK HERE TO LOGIN
REGULAR CONTENT
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Rate & Comment (0)
Background and Objective:
Shockwave lithotripsy (SWL) and Ureteroscopy (URS) are minimally invasive treatment alternatives for kidney stones. Although less invasive, SWL subjects the renal parenchyma to a high level of energy and the potential to cause renal injury. The ability to detect renal injury post-SWL in a reliable and non-invasive way would be clinically beneficial. KIM-1 and NAG are 2 proteins secreted by the kidney into the urine and have been found to be sensitive markers of acute kidney injury in transplant patients. The aim of this work was to measure urinary levels of KIM-1 and NAG in kidney stone patients treated by SWL, URS and in non-stone volunteers.
Methods:
Kidney stone patients treated by SWL (n=50) and URS (n=10) were recruited. Voided urine samples were collected before and 2-3 hours following URS and SWL. Additionally, further urinary specimens were collected 2 days and 2 weeks post SWL. Voided urine samples from healthy volunteers were also collected.
Results:
Mean KIM-1 values were increased in kidney stone patients when compared to volunteers. KIM-1 and NAG levels significantly increased post SWL and returned to baseline within 2 weeks post SWL. Poor kidney function was significantly associated with increased biomarker activity both in baseline and post SWL measurements. There was no significant change in urinary KIM-1 and NAG concentrations before and after ureteroscopy.
Conclusions:
Kim-1 and NAG levels significantly increased post SWL treatment suggesting a potential role for these urinary markers in identifying patients at higher risk of tissue injury.
Shockwave lithotripsy (SWL) and Ureteroscopy (URS) are minimally invasive treatment alternatives for kidney stones. Although less invasive, SWL subjects the renal parenchyma to a high level of energy and the potential to cause renal injury. The ability to detect renal injury post-SWL in a reliable and non-invasive way would be clinically beneficial. KIM-1 and NAG are 2 proteins secreted by the kidney into the urine and have been found to be sensitive markers of acute kidney injury in transplant patients. The aim of this work was to measure urinary levels of KIM-1 and NAG in kidney stone patients treated by SWL, URS and in non-stone volunteers.
Methods:
Kidney stone patients treated by SWL (n=50) and URS (n=10) were recruited. Voided urine samples were collected before and 2-3 hours following URS and SWL. Additionally, further urinary specimens were collected 2 days and 2 weeks post SWL. Voided urine samples from healthy volunteers were also collected.
Results:
Mean KIM-1 values were increased in kidney stone patients when compared to volunteers. KIM-1 and NAG levels significantly increased post SWL and returned to baseline within 2 weeks post SWL. Poor kidney function was significantly associated with increased biomarker activity both in baseline and post SWL measurements. There was no significant change in urinary KIM-1 and NAG concentrations before and after ureteroscopy.
Conclusions:
Kim-1 and NAG levels significantly increased post SWL treatment suggesting a potential role for these urinary markers in identifying patients at higher risk of tissue injury.
Background and Objective:
Shockwave lithotripsy (SWL) and Ureteroscopy (URS) are minimally invasive treatment alternatives for kidney stones. Although less invasive, SWL subjects the renal parenchyma to a high level of energy and the potential to cause renal injury. The ability to detect renal injury post-SWL in a reliable and non-invasive way would be clinically beneficial. KIM-1 and NAG are 2 proteins secreted by the kidney into the urine and have been found to be sensitive markers of acute kidney injury in transplant patients. The aim of this work was to measure urinary levels of KIM-1 and NAG in kidney stone patients treated by SWL, URS and in non-stone volunteers.
Methods:
Kidney stone patients treated by SWL (n=50) and URS (n=10) were recruited. Voided urine samples were collected before and 2-3 hours following URS and SWL. Additionally, further urinary specimens were collected 2 days and 2 weeks post SWL. Voided urine samples from healthy volunteers were also collected.
Results:
Mean KIM-1 values were increased in kidney stone patients when compared to volunteers. KIM-1 and NAG levels significantly increased post SWL and returned to baseline within 2 weeks post SWL. Poor kidney function was significantly associated with increased biomarker activity both in baseline and post SWL measurements. There was no significant change in urinary KIM-1 and NAG concentrations before and after ureteroscopy.
Conclusions:
Kim-1 and NAG levels significantly increased post SWL treatment suggesting a potential role for these urinary markers in identifying patients at higher risk of tissue injury.
Shockwave lithotripsy (SWL) and Ureteroscopy (URS) are minimally invasive treatment alternatives for kidney stones. Although less invasive, SWL subjects the renal parenchyma to a high level of energy and the potential to cause renal injury. The ability to detect renal injury post-SWL in a reliable and non-invasive way would be clinically beneficial. KIM-1 and NAG are 2 proteins secreted by the kidney into the urine and have been found to be sensitive markers of acute kidney injury in transplant patients. The aim of this work was to measure urinary levels of KIM-1 and NAG in kidney stone patients treated by SWL, URS and in non-stone volunteers.
Methods:
Kidney stone patients treated by SWL (n=50) and URS (n=10) were recruited. Voided urine samples were collected before and 2-3 hours following URS and SWL. Additionally, further urinary specimens were collected 2 days and 2 weeks post SWL. Voided urine samples from healthy volunteers were also collected.
Results:
Mean KIM-1 values were increased in kidney stone patients when compared to volunteers. KIM-1 and NAG levels significantly increased post SWL and returned to baseline within 2 weeks post SWL. Poor kidney function was significantly associated with increased biomarker activity both in baseline and post SWL measurements. There was no significant change in urinary KIM-1 and NAG concentrations before and after ureteroscopy.
Conclusions:
Kim-1 and NAG levels significantly increased post SWL treatment suggesting a potential role for these urinary markers in identifying patients at higher risk of tissue injury.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}